Antidepressant Medication Use With Depressed Youth & Possible Suicide Risk Controversy

Antidepressant Medication Use in Youth and Suicide Risk Controversy
Recent Food and Drug Administration Hearings and Interim Recommendations: On Sept. 14, 04, mental health professionals, researchers, mental health advocates, and concerned parents and youth presented additional information to the Psychopharmacologic Drugs and Pediatric Advisory Committee (PDPAC) to the FDA. Meeting minutes included background information, researcher testimony, DCF PMAC Consensus Statements & recommendations.